Biosimilar Legislation Making Moves in the Right Direction
Biosimilar therapies might be here to stay, but the regulatory landscape around these products is still evolving, said Lakesha Farmer, Senior Director, Strategic Accounts, ION Oncology Practice Network at Cencora. “There are several legislative efforts currently in motion to address several perceived impediments to the biosimilar approvals and launches that we see today.”
